MedPath

Improving wound healing in chronic ulcus cruris venosum with native fibrin enriched with endogenous platelets and vagal stimulation with p-Stim (a pilot study) - Improving wound healing

Phase 1
Conditions
The study aims to evaluate the improvement in wound healing in chronic crural venous ulcers by comparing additive application of autologous fibrin enriched with autologous thrombocyted to standardized treatment in patients aged 18-80 years with ulcers from 10 cm2 to 100 cm2 in size that have been present for 3-36 months. We also examine the wound healing improvement with auricular electro-stimulation and the effect of the simultaneous use of PRF and electro-stimulation.
MedDRA version: 12.0Level: LLTClassification code 10045346Term: Ulcerated varicose veins
Registration Number
EUCTR2009-017050-12-AT
Lead Sponsor
Sektion Chirurgische Forschung
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

male and female patients aged 18-80 years, ulcers of at least 10cm2 and at most 100cm2 in size, ulcers that have been presented for at least 3 months and at most 3 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

renal failure, gravidity, lactation period, insuline dependent diabetes, cachexia, dementia, hematological diseases, malignoma, positive thrombophilia screening, peripheral arterial occlusive disease, ulcera that have been present more than 3 years and less than 3 months, pretreatment with growth factors, treatment with drugs that provide wound healing

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: healing process of crural venous ulcera with application of autologous platelet rich fibrin with or without electrostimulation in comparison to standardized treatment ;Secondary Objective: pain reduction;Primary end point(s): reduction of wound area<br>pain relief
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath